BridgeBio Pharma Inc (BBIO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

421 KIPLING STREET PALO ALTO, CA 94301

Bridgebio Pharma, Inc. operates as a bio technology company. The Company focuses on development of medicines for genetic diseases. Bridgebio Pharma serves patients worldwide.

View SEC Filings from BBIO instead.
Q3 2019 All Institutions Hedge Funds 1
To trade BBIO now:
Filers who had this stock in their top 10: 5 3 (0.31%)
13F Filers holding this stock: 71 12 (1.25%)
Aggregate 13F shares on 09/30/2019: 103.054 Million 73.692 Million
Aggregate 13F shares on 06/30/2019: 99.628 Million 74.711 Million
Percent change: 3.44% -1.36%
Funds creating new positions: 29
Funds Adding to an existing position: 17
Funds closing out their position: 17 7
Funds reducing their position: 14 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BBIO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STOLZ BRIAN M. CHIEF OPERATING OFFICER

  • Officer
22,839 2019-11-13 2

YAU YI CHING CHIEF ACCOUNTING OFFICER

  • Officer
0 2019-11-13 2

SINHA UMA CHIEF SCIENTIFIC OFFICER

  • Officer
343,581 2019-09-25 2

SCHELLER RICHARD H

  • Director
0 2019-09-16 2

AGUIAR ERIC

  • Director
0 2019-09-11 1

TURTLE CAMERON CHIEF BUSINESS OFFICER

  • Officer
95,155 2019-09-04 2

MOMTAZEE JAMES C

  • Director
1,443 2019-08-13 1

VIKING GLOBAL INVESTORS LP

VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

VIKING GLOBAL OPPORTUNITIES GP LLC

HALVORSEN OLE ANDREAS

OTT DAVID C.

SHABET ROSE SHARON

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
0 2019-07-10 2

KUMAR NEIL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
24,575,501 2019-07-03 2

SATVAT ALI J.

  • Director
  • 10% Owner
24,575,501 2019-07-03 1

HENDERSON MICHAEL THOMAS SEE REMARKS

  • Officer
180,767 2019-07-01 2

MCCORMICK FRANK CHAIRMAN OF ONCOLOGY

  • Officer
1,361,426 2019-07-01 2

STEPHENSON BRIAN C SEE REMARK

  • Officer
368,446 2019-07-01 2

HOMCY CHARLES J CHAIRMAN OF PHARMACEUTICALS

  • Officer
  • Director
1,361,426 2019-07-01 2

KKR GENETIC DISORDER L.P.

ROBERTS GEORGE R

KRAVIS HENRY R

KKR MANAGEMENT LLC

KKR & CO. INC.

KKR GROUP HOLDINGS CORP.

KKR MANAGEMENT HOLDINGS CORP

KKR MANAGEMENT HOLDINGS L.P.

KKR GENETIC DISORDER GP LLC

  • 10% Owner
36,900,661 2019-07-01 2

VIKING GLOBAL PERFORMANCE LLC

VIKING GLOBAL EQUITIES MASTER LTD.

VIKING LONG FUND GP LLC

VIKING LONG FUND MASTER LTD.

HALVORSEN OLE ANDREAS

OTT DAVID C.

SHABET ROSE SHARON

  • 10% Owner
38,406,607 2019-07-01 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

STOLZ BRIAN M. - Officer CHIEF OPERATING OFFICER

2019-11-13 A 22,839 a 22,839 22,839.00 direct

STOLZ BRIAN M. - Officer CHIEF OPERATING OFFICER

2019-11-13 A 106,469 a 106,469 22,839.00 direct

YAU YI CHING - Officer CHIEF ACCOUNTING OFFICER

2019-11-13 A 20,376 a 20,376 0.00 direct

STOLZ BRIAN M. - Officer CHIEF OPERATING OFFICER

2019-11-13 A 102,081 a 102,081 22,839.00 direct

YAU YI CHING - Officer CHIEF ACCOUNTING OFFICER

2019-11-13 A 78,148 a 78,148 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments